L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea · Delayed Price · Currency is KRW

98,600

+1,600 (1.65%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Medical Products	72.09B	65.93B	52.57B	45.68B	32.97B
Medical Products Growth	9.35%	25.40%	15.10%	38.53%	13.11%
Total	72.09B	65.93B	52.57B	45.68B	32.97B
Total Growth	9.35%	25.40%	15.10%	38.53%	13.11%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
South Korea	67.51B	61.99B	48.67B	43.45B	-
South Korea Growth	8.90%	27.36%	12.01%	-	-
Export	4.58B	3.94B	3.90B	2.22B	-
Export Growth	16.42%	0.93%	75.28%	-	-
Total	72.09B	65.93B	52.57B	45.68B	-
Total Growth	9.35%	25.40%	15.10%	-	-

Source: S&P Global Market Intelligence.